Your institution may have access to this item. Find your institution then sign in to continue.
Title
People.
Abstract
The article announces career changes of several people including Margaret Hamburg who resigned as U.S. Food and Drug Administration's commissioner, Martin Babler who has named to ZS Pharma Inc.'s board of directors, Anthony Boral who was appointed as senior vice president by Blueprint Medicines.